- About this Journal ·
- Abstracting and Indexing ·
- Advance Access ·
- Aims and Scope ·
- Article Processing Charges ·
- Articles in Press ·
- Author Guidelines ·
- Bibliographic Information ·
- Citations to this Journal ·
- Contact Information ·
- Editorial Board ·
- Editorial Workflow ·
- Free eTOC Alerts ·
- Publication Ethics ·
- Reviewers Acknowledgment ·
- Submit a Manuscript ·
- Subscription Information ·
- Table of Contents
Journal of Ophthalmology
Volume 2010 (2010), Article ID 521204, 6 pages
Aldo-Keto Reductases in the Eye
1Department of Ophthalmology & Visual Sciences, Washington University School of Medicine, St. Louis, MO 63110, USA
2Program in Genetics, Molecular, and Cell Biology, University of Southern California School of Medicine, Los Angeles, CA 90033, USA
3Biochemistry Division, National Institute of Nutrition, Hyderabad-500 604, India
4Department of Ophthalmology, Rocky Mountain Lions Eye Institute, University of Colorado Denver, Aurora, CO 80111, USA
Received 7 February 2010; Accepted 15 March 2010
Academic Editor: Ram H. Nagaraj
Copyright © 2010 Shun Ping Huang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
- L. P. Aiello, T. W. Gardner, G. L. King, et al., “Diabetic retinopathy,” Diabetes Care, vol. 21, pp. 143–156, 1998.
- P. E. Stanga, S. R. Boyd, and A. M. P. Hamilton, “Ocular manifestations of diabetes mellitus,” Current Opinion in Ophthalmology, vol. 10, no. 6, pp. 483–489, 1999.
- S. F. Yan, R. Ramasamy, and A. M. Schmidt, “The receptor for advanced glycation endproducts (RAGE) and cardiovascular disease,” Expert Reviews in Molecular Medicine, vol. 11, article e9, 2009.
- N. Das Evcimen and G. L. King, “The role of protein kinase C activation and the vascular complications of diabetes,” Pharmacological Research, vol. 55, no. 6, pp. 498–510, 2007.
- J. H. Kinoshita and C. Nishimura, “The involvement of aldose reductase in diabetic complications,” Diabetes-Metabolism Reviews, vol. 4, no. 4, pp. 323–337, 1988.
- M. Brownlee, “The pathobiology of diabetic complications: a unifying mechanism,” Diabetes, vol. 54, no. 6, pp. 1615–1625, 2005.
- A. Y. W. Lee, S. K. Chung, and S. S. M. Chung, “Demonstration that polyol accumulation is responsible for diabetic cataract by the use of transgenic mice expressing the aldose reductase gene in the lens,” Proceedings of the National Academy of Sciences of the United States of America, vol. 92, no. 7, pp. 2780–2784, 1995.
- D. J. Hyndman and T. G. Flynn, “Sequence and expression levels in human tissues of a new member of the aldo-keto reductase family,” Biochimica et Biophysica Acta, vol. 1399, no. 2-3, pp. 198–202, 1998.
- D. Cao, S. T. Fan, and S. S. M. Chung, “Identification and characterization of a novel human aldose reductase-like gene,” Journal of Biological Chemistry, vol. 273, no. 19, pp. 11429–11435, 1998.
- B. Crosas, D. J. Hyndman, O. Gallego, et al., “Human aldose reductase and human small intestine aldose reductase are efficient retinal reductases: consequences for retinoid metabolism,” Biochemical Journal, vol. 373, no. 3, pp. 973–979, 2003.
- S. A. Vinores, P. A. Campochiaro, E. H. Williams, E. E. May, W. R. Green, and R. L. Sorenson, “Aldose reductase expression in human diabetic retina and retinal pigment epithelium,” Diabetes, vol. 37, no. 12, pp. 1658–1664, 1988.
- Y. Akagi, Y. Yajima, and P. F. Kador, “Localization of aldose reductase in the human eye,” Diabetes, vol. 33, no. 6, pp. 562–566, 1984.
- I. Tarle, B. W. Borhani, D. K. Wilson, F. A. Quiocho, and J. M. Petrash, “Probing the active site of human aldose reductase. Site-directed mutagenesis of Asp-43, Tyr-48, Lys-77, and His-110,” Journal of Biological Chemistry, vol. 268, no. 34, pp. 25687–25693, 1993.
- L. W. Reneker, Q. Chen, A. Bloch, L. Xie, G. Schuster, and P. A. Overbeek, “Chick 1-crystallin enhancer influences mouse A-crystallin promoter activity in transgenic mice,” Investigative Ophthalmology and Visual Science, vol. 45, no. 11, pp. 4083–4090, 2004.
- A. M. Joussen, V. Poulaki, M. L. Le, et al., “A central role for inflammation in the pathogenesis of diabetic retinopathy,” FASEB Journal, vol. 18, no. 12, pp. 1450–1452, 2004.
- C.-D. Hsu, S. Kymes, and J. M. Petrash, “A transgenic mouse model for human autosomal dominant cataract,” Investigative Ophthalmology and Visual Science, vol. 47, no. 5, pp. 2036–2044, 2006.
- S. D. Varma, S. S. Shocket, and R. D. Richards, “Implications of aldose reductase in cataracts in human diabetes,” Investigative Ophthalmology and Visual Science, vol. 18, no. 3, pp. 237–241, 1979.